GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India · Delayed Price · Currency is INR 2,402.90
+2.30 (0.10%)
At close: Jul 7, 2026
BOM:500660 Market Cap
BOM:500660 has a market cap or net worth of 407.07 billion as of July 7, 2026. Its market cap has decreased by -28.62% in one year.
Market Cap
407.07B
Enterprise Value
379.83B
Revenue
38.22B
Ranking
n/a
PE Ratio
39.29
Stock Price
2,402.90
Market Cap Chart
Since October 25, 2001, BOM:500660's market cap has increased from 19.14B to 407.07B, an increase of 2,026.77%. That is a compound annual growth rate of 13.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 407.07B | -2.75% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.14T |
| Lupin | 1.14T |
| Abbott India | 570.58B |
| J. B. Chemicals & Pharmaceuticals | 383.85B |
| Rubicon Research | 224.42B |
| Granules India | 211.72B |
| AstraZeneca Pharma India | 205.56B |
| Caplin Point Laboratories | 199.54B |